2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Migraines: new trials by email Literature Review of Migraines trials Research Report on Migraines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031) Telcagepant 140 mg, Talcagepant 280 mg, Placebo - Migraines | Phase 3 | Completed | Merck Sharp & Dohme LLC | 1935 | 2008-08-14 | 2018-10-18 |
| A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488. divalproex sodium - Migraines | Phase 3 | Completed | Abbott | 114 | 2004-07-01 | 2007-07-31 |
Brain Diseases (2) · Central Nervous System Diseases (2) · Headache Disorders (2) · Headache Disorders, Primary (2) · Nervous System Diseases (2)
Valproic Acid (1) · telcagepant (1)
Abbott (1) · Merck Sharp & Dohme LLC (1)
United States (1)